Danish vaccine pioneer Bavarian Nordic is embroiled in a heated bidding war. Private equity giants Nordic Capital and Permira want to buy the company for 19 billion Danish kroner and take it private....
You need to create a user account to read this article.
With a subscription you unlock more content on BioStock.